290 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Fang P, Pinnix CC, Wu SY, Lee HC, Patel KK, Saini N, Becnel MR, Kaufman G, Thomas SK, Orlowski RZ, Amini B, Lin P, Dabaja BS, Gunther JR. Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 38070713 DOI: 10.1016/j.ijrobp.2023.11.039  0.724
2023 Kahn J, Dabaja B, Wu S, Kelly K, Berkahn L, Pavlovsky A, Sureda A, LaCasce A. Classic Hodgkin lymphoma. Hematological Oncology. PMID 38037872 DOI: 10.1002/hon.3239  0.332
2023 Alkhaldi H, Reinhardt A, Barnett M, Kundu S, Hosing C, Ramdial J, Saini N, Srour S, Alousi A, Kebriaei P, Popat U, Qazilbash M, Champlin R, Shpall EJ, Gulbis A, ... ... Dabaja B, et al. HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANT FOR RELAPSED OR REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA. Transplantation and Cellular Therapy. PMID 37607645 DOI: 10.1016/j.jtct.2023.08.019  0.577
2023 Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David KA, Evens AM, Pandya K, Bair SM, ... ... Dabaja BS, et al. Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood Advances. PMID 37603594 DOI: 10.1182/bloodadvances.2023010700  0.735
2023 Wu SY, Fang PQ, Wang EB, Ahmed S, Duvic M, Jain P, Castillo LEM, Nair R, Steiner RE, Strati P, Huen AO, Iyer SP, Pinnix CC, Dabaja BS, Gunther JR. Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Advances in Radiation Oncology. 8: 101279. PMID 37448588 DOI: 10.1016/j.adro.2023.101279  0.732
2022 Damron EP, Qazilbash MH, Fang PQ, Wu SY, Dabaja BS, Rondon G, Hosing C, Champlin RE, Bashir Q, Shpall EJ, Knafl MK, Lee HC, Manasanch EE, Patel K, Thomas SK, et al. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplantation and Cellular Therapy. 29: 37.e1-37.e7. PMID 37753818 DOI: 10.1016/j.jtct.2022.10.020  0.716
2022 Wu SY, Short NJ, Nasr L, Dabaja BS, Fang PQ. Central Nervous System Prophylaxis and Treatment in Acute Leukemias. Current Treatment Options in Oncology. 23: 1829-1844. PMID 36510037 DOI: 10.1007/s11864-022-01032-5  0.393
2022 Dabaja BS, Ng AK. Let us give our Hodgkin's lymphoma patients the radiation they need. Leukemia & Lymphoma. 1-2. PMID 36107106 DOI: 10.1080/10428194.2022.2123237  0.368
2022 Wilkinson AJ, Nader ME, Roberts D, Duvic M, Gunther JR, Dabaja BS, Gidley PW. Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal. The Laryngoscope. PMID 36054317 DOI: 10.1002/lary.30377  0.575
2022 Afrough A, Alsfeld LC, Milton DR, Delgado R, Popat UR, Nieto Y, Kebriaei P, Oran B, Saini N, Srour S, Hosing C, Cheema FH, Ahmed S, Manasanch EE, Lee HC, ... ... Dabaja BS, et al. Long-term outcomes of allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma. Transplantation and Cellular Therapy. PMID 35605883 DOI: 10.1016/j.jtct.2022.05.023  0.529
2022 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Chen W, Dabaja B, Daly ME, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Johnston PB, et al. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 322-334. PMID 35390768 DOI: 10.6004/jnccn.2022.0021  0.39
2021 Kahn JM, Yang JC, Yahalom J, Dabaja BS, Vapiwala N, Hoppe BS, Tseng YD, Pinnix CC, Parikh RR, Sim AJ, Plastaras JP, Gunther JR. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 34601699 DOI: 10.1007/s13187-021-02098-9  0.685
2021 Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, ... ... Dabaja B, et al. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica. PMID 33951890 DOI: 10.3324/haematol.2021.278311  0.716
2021 Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, ... ... Dabaja BS, et al. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leukemia & Lymphoma. 1-8. PMID 33942701 DOI: 10.1080/10428194.2021.1919656  0.741
2021 Fang PQ, Gunther JR, Wu SY, Dabaja BS, Nastoupil LJ, Ahmed S, Neelapu SS, Pinnix CC. Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy. Frontiers in Oncology. 11: 648655. PMID 33842363 DOI: 10.3389/fonc.2021.648655  0.723
2021 Hoppe BS, Advani R, Milgrom SA, Bakst RL, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Mansur DB, Metzger ML, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, et al. Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria. International Journal of Radiation Oncology, Biology, Physics. PMID 33774076 DOI: 10.1016/j.ijrobp.2021.03.035  0.573
2021 Morse DC, Park KE, Chitsazzadeh V, Li S, Young K, Gunther JR, Dabaja BS, Duvic M. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 33741766 DOI: 10.1097/PGP.0000000000000648  0.597
2021 Qi SN, Li YX, Specht L, Oguchi M, Tsang R, Ng A, Suh CO, Ricardi U, Mac Manus M, Dabaja B, Yahalom J. Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. PMID 33581262 DOI: 10.1016/j.ijrobp.2021.02.011  0.403
2021 Manasanch EE, Kunacheewa C, Claussen CM, Lee HC, Thomas SK, Gunther J, Pinnix CC, Dabaja BS, Amini B, Alexanian R, Orlowski RZ, Dong W, Feng L, Weber DM. Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up. Blood Cancer Journal. 11: 17. PMID 33563896 DOI: 10.1038/s41408-021-00419-1  0.492
2021 Strati P, Cheng PTM, Steiner RE, Alcedo Andrade PE, Feng L, Sano D, Rao VA, Singh P, Miranda R, Gunther JR, Pinnix CC, Dabaja BS, Cuglievan B, Xing K, Villa D, et al. Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis. British Journal of Haematology. 192: 560-567. PMID 33517581 DOI: 10.1111/bjh.17281  0.752
2021 Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, ... ... Dabaja BS, et al. The impact of cell-of-origin, MYC/Bcl-2 dual expression and rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leukemia & Lymphoma. 1-12. PMID 33480830 DOI: 10.1080/10428194.2020.1869965  0.745
2020 Dabaja BS, Milgrom SA, Wirth A. Secondary central nervous system diffuse large cell lymphoma: an opportunity for radiation therapy to improve outcomes. Leukemia & Lymphoma. 62: 1-4. PMID 33356706 DOI: 10.1080/10428194.2020.1864353  0.369
2020 Fang P, Gunther JR, Pinnix CC, Dong W, Strati P, Nastoupil LJ, Steiner RE, Ahmed S, Damron EP, Fowler N, Nair R, Westin JR, Neelapu S, Ha CS, Dabaja BS. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. International Journal of Radiation Oncology, Biology, Physics. PMID 33309978 DOI: 10.1016/j.ijrobp.2020.11.070  0.71
2020 Moreno AC, Gunther JR, Milgrom S, Fuller CD, Williamson T, Liu A, Wu R, Zhu XR, Dabaja BS, Pinnix CC. Effect of Deep Inspiration Breath Hold on Normal Tissue Sparing With Intensity Modulated Radiation Therapy Versus Proton Therapy for Mediastinal Lymphoma. Advances in Radiation Oncology. 5: 1255-1266. PMID 33305086 DOI: 10.1016/J.Adro.2020.08.004  0.727
2020 Ballas LK, Metzger ML, Milgrom SA, Advani R, Bakst RL, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, et al. Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria. Leukemia & Lymphoma. 1-14. PMID 33274673 DOI: 10.1080/10428194.2020.1852559  0.541
2020 Pinnix CC, Gunther JR, Fang P, Bankston ME, Milgrom SA, Boyce D, Lee HJ, Nair R, Steiner R, Strati P, Ahmed S, Iyer SP, Westin J, Parmar S, Rodriguez MA, ... ... Dabaja BS, et al. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy. Jama Network Open. 3: e2013935. PMID 32990738 DOI: 10.1001/jamanetworkopen.2020.13935  0.758
2020 Gunther JR, Pinnix CC, Glober GR, Christopherson KM, Fang P, Lee HJ, Ahmed S, Steiner RE, Nair R, Strati P, Neelapu SS, Nastoupil LJ, Dabaja BS. Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes? Ejhaem. 1: 272-276. PMID 32864660 DOI: 10.1002/jha2.1  0.728
2020 Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, ... ... Dabaja BS, et al. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Advances in Radiation Oncology. 5: 567-572. PMID 32775771 DOI: 10.1016/J.Adro.2020.04.038  0.352
2020 Dabaja BS, Ng AK, Terezakis SA, Plastaras JP, Yunes M, Wilson LD, Yang J, Gunther JR, Specht L, Yahalom J. ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma. International Journal of Radiation Oncology, Biology, Physics. PMID 32768256 DOI: 10.1016/J.Ijrobp.2020.05.063  0.602
2020 Furqan F, Watson G, Samaniego F, Fayad LE, Morrison MW, Thompson PA, Steiner RE, Chi L, Dabaja B, Pinnix CC, Neelapu SS, Nastoupil LJ, Strati P. Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement. Leukemia & Lymphoma. 1-5. PMID 32650677 DOI: 10.1080/10428194.2020.1791849  0.615
2020 Christopherson KM, Gunther JR, Fang P, Peterson SL, Roach KE, Wong PF, Mirkovic D, Lim TY, Wang H, Wang XA, Wang C, Garcia J, Dabaja BS, Pinnix CC. Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT. Clinical and Translational Radiation Oncology. 24: 79-82. PMID 32642563 DOI: 10.1016/J.Ctro.2020.05.013  0.715
2020 Zhu LL, Martin RM, Gunther JR, Wong PF, Hancock D, Moreno AC, Dabaja BS, Pinnix CC. Daily computed tomography image guidance: dosimetric advantages outweigh low-dose radiation exposure for treatment of mediastinal lymphoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32593645 DOI: 10.1016/J.Radonc.2020.06.028  0.727
2020 Pinnix CC, Gunther JR, Dabaja BS, Strati P, Fang P, Hawkins MC, Adkins S, Westin J, Ahmed S, Fayad L, Lee HJ, Nair R, Steiner RE, Iyer SP, Rodriguez MA, et al. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. Blood Advances. 4: 2871-2883. PMID 32589728 DOI: 10.1182/Bloodadvances.2020001837  0.753
2020 Dabaja B, Milgrom S, Parikh R, Wu S, Tsang R. The Challenges of Applying Radiation in Primary Central Nervous System Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 107: 398-400. PMID 32531380 DOI: 10.1016/J.Ijrobp.2020.02.466  0.442
2020 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Bierman PJ, Boughan KM, Dabaja B, Gordon LI, Hernandez-Ilizaliturri FJ, Herrera AF, Hochberg EP, Huang J, et al. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 755-781. PMID 32502987 DOI: 10.6004/Jnccn.2020.0026  0.396
2020 Ning MS, Frances McAleer M, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Brandon Gunn G, Klopp AH, ... Dabaja BS, et al. Mitigating the Impact of COVID-19 on Oncology: Clinical and Operational Lessons from a Prospective Radiation Oncology Cohort Tested for COVID-19. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32474129 DOI: 10.1016/J.Radonc.2020.05.037  0.344
2020 Qi S, Milgrom S, Dabaja B, Tsang R, Levis M, Ricardi U, Lopez-Alonso R, Dann EJ, Ng A, Yahalom J. Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease. Blood Advances. 4: 2064-2072. PMID 32396621 DOI: 10.1182/Bloodadvances.2019001265  0.373
2020 Paul S, Rausch CR, Jain N, Kadia T, Ravandi F, DiNardo CD, Welch MA, Dabaja BS, Daver N, Garcia-Manero G, Wierda W, Pemmaraju N, Montalban Bravo G, Thompson P, Verstovsek S, et al. Treating Leukemia in the Time of COVID-19. Acta Haematologica. 1-13. PMID 32392559 DOI: 10.1159/000508199  0.381
2020 Glober G, Gunther J, Fang P, Milgrom S, Korivi BR, Jensen CT, Wagner-Bartak NA, Ahmed S, Lee HJ, Nair R, Steiner R, Parmar S, Iyer S, Westin J, Fayad L, ... ... Dabaja BS, et al. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. Clinical Lymphoma, Myeloma & Leukemia. PMID 32291233 DOI: 10.1016/J.Clml.2020.02.008  0.734
2020 Yahalom J, Dabaja BS, Ricardi U, Ng A, Mikhaeel NG, Vogelius IR, Illidge TM, Qi S, Wirth A, Specht L. ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic. Blood. PMID 32275740 DOI: 10.1182/Blood.2020006028  0.432
2020 Wirth A, Mikhaeel NG, Pauline Aleman BM, Pinnix CC, Constine LS, Wilmot JP, Ricardi U, Illidge TM, Eich HT, Hoppe BS, Dabaja B, Ng AK, Kirova Y, Berthelsen AK, Dieckmann K, et al. Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. International Journal of Radiation Oncology, Biology, Physics. PMID 32272184 DOI: 10.1016/j.ijrobp.2020.03.019  0.6
2020 Dabaja BS, Ng AK, Terezakis SA, Plastaras JP, Yunes M, Wilson LD, Specht L, Yahalom J. Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies. International Journal of Radiation Oncology, Biology, Physics. 106: 279-281. PMID 31928641 DOI: 10.1016/J.Ijrobp.2019.10.029  0.432
2020 Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, ... ... Dabaja BS, et al. New Paradigm for Radiation in Multiple Myeloma: lower yet effective dose to avoid radiation toxicity. Haematologica. PMID 31919088 DOI: 10.3324/Haematol.2019.235804  0.729
2020 Dabaja B. Would Negative Interim PET Be Enough to Omit Radiation in Patients With Early Hodgkin Lymphoma? The Answer Is No. International Journal of Radiation Oncology, Biology, Physics. 106: 16-17. PMID 31836077 DOI: 10.1016/J.Ijrobp.2019.08.014  0.473
2020 Steiner R, Cramer FM, Singh P, Becnel M, Alcedo PE, Chin CK, Cuglievan B, Strati P, Ahmed S, Samaniego F, Nair R, Gunther JR, Pinnix CC, Fang P, Dabaja BS, et al. Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin’s lymphoma in a real-world setting. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E20020  0.704
2020 Nair R, Pinnix CC, Gunther JR, Strati P, Westin J, Fayad L, Hagemeister FB, Iyer SP, Nastoupil LJ, Parmar S, Rodriguez MA, Steiner R, Dabaja BS, Fang P, Flowers C, et al. M.D. Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma. Journal of Clinical Oncology. 38: e20013-e20013. DOI: 10.1200/Jco.2020.38.15_Suppl.E20013  0.73
2020 Steiner RE, Becnel MR, Cuglievan B, Nair R, Singh P, Strati P, Jain P, Ahmed S, Samaniego F, Gunther JR, Pinnix CC, Fang P, Dabaja BS, Feng L, Lee HJ. Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant Blood. 136: 28-29. DOI: 10.1182/blood-2020-138996  0.417
2020 Liu Y, Augustyn A, Gunther J, Fang P, Nastoupil L, Ahmed S, Strati P, Nair R, Steiner R, Westin J, Rodriguez M, Neelapu S, Flowers C, Khoury J, Medeiros L, ... Dabaja B, et al. Radiation Therapy for Refractory High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements International Journal of Radiation Oncology*Biology*Physics. 108: S168. DOI: 10.1016/j.ijrobp.2020.07.939  0.376
2020 Gjyshi O, Boyce-Fappiano D, Gunther J, Fang P, Nastoupil L, Nair R, Steiner R, Strati P, Ahmed S, Khoury J, Westin J, Rodriguez M, Fayad L, Neelapu S, Flowers C, ... Dabaja B, et al. Assessing the Role of Radiation Therapy for Primary Mediastinal Large B-Cell Lymphoma in the Setting of PET Avid Disease after Chemotherapy International Journal of Radiation Oncology*Biology*Physics. 108: S116. DOI: 10.1016/j.ijrobp.2020.07.2310  0.397
2020 Gunther J, Dabaja B, Fang P, Anakwenze C, Manasanch E, Lee H, Patel K, Kaufman G, Thomas S, Orlowski R, Weber D, Wang X, Amini B, Lin P, Pinnix C. Management and Long-Term Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 108: e756. DOI: 10.1016/j.ijrobp.2020.07.181  0.327
2019 Sunderland AJ, Steiner RE, Al Zahrani M, Pinnix CC, Dabaja BS, Gunther JR, Nastoupil LJ, Jerkeman M, Joske D, Cull G, El-Galaly T, Villa D, Cheah CY. An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. Cancer Medicine. PMID 31808316 DOI: 10.1002/Cam4.2732  0.72
2019 Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, et al. Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. Journal of Cardiovascular Imaging. 27: 268-279. PMID 31614398 DOI: 10.4250/jcvi.2019.27.e38  0.672
2019 Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Ju Lee H, Fowler N, et al. Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leukemia & Lymphoma. 1-5. PMID 31373240 DOI: 10.1080/10428194.2019.1644333  0.756
2019 Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Advances. 3: 2035-2039. PMID 31289030 DOI: 10.1182/Bloodadvances.2019030858  0.77
2019 Andraos TY, Ayoub Z, Nastoupil LJ, Milgrom SA, Pinnix CC, Ng SP, Gunther JR, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Dabaja BS. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma. Leukemia & Lymphoma. 1-8. PMID 31234671 DOI: 10.1080/10428194.2019.1627535  0.756
2019 Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, ... ... Dabaja BS, et al. Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated? Clinical Lymphoma, Myeloma & Leukemia. PMID 31133526 DOI: 10.1016/J.Clml.2019.04.015  0.658
2019 Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, ... ... Dabaja BS, et al. Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood Advances. 3: 1356-1367. PMID 31036721 DOI: 10.1182/Bloodadvances.2018029140  0.772
2019 Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, et al. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head & Neck. 41: 1546. PMID 30990235 DOI: 10.1002/Hed.25738  0.593
2019 Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy. Leukemia & Lymphoma. 1-9. PMID 30942648 DOI: 10.1080/10428194.2019.1597081  0.763
2019 Andraos T, Ayoub Z, Nastoupil L, Pinnix C, Milgrom S, Gunther J, Ng SP, Fowler N, Neelapu S, Samaniego F, Dabaja B. Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes. Clinical Lymphoma, Myeloma & Leukemia. PMID 30935940 DOI: 10.1016/J.Clml.2019.02.011  0.704
2019 Dabaja BS, Hoppe BS, Plastaras JP. Erratum: Proton therapy for adults with mediastinal lymphomas: The International Lymphoma Radiation Oncology Group guidelines (Blood (2018) 132, 16 (1635-1646) DOI: 10.1182/blood-2018-03-837633) Blood. 133: 1384-1385. PMID 30898780 DOI: 10.1182/Blood-2019-02-900738  0.409
2019 Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, ... ... Dabaja B, et al. Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG. International Journal of Radiation Oncology, Biology, Physics. PMID 30858143 DOI: 10.1016/J.Ijrobp.2019.03.004  0.421
2019 Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, ... ... Dabaja B, et al. Frontline Antibiotic Therapy for Early Stage Helicobacter Pylori Negative Gastric MALT Lymphoma. American Journal of Hematology. PMID 30785215 DOI: 10.1002/Ajh.25447  0.682
2019 An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 131: 88-92. PMID 30773193 DOI: 10.1016/J.Radonc.2018.12.003  0.525
2019 Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee H, Westin J, Fowler N, Nastoupil L, Dabaja B. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma. International Journal of Radiation Oncology, Biology, Physics. PMID 30769175 DOI: 10.1016/J.Ijrobp.2019.02.002  0.763
2019 Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, et al. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Scientific Reports. 9: 1322. PMID 30718585 DOI: 10.1038/S41598-018-37197-Z  0.697
2019 Yoder AK, Gunther JR, Milgrom SA, Pham M, Hancock D, McSpadden K, Garcia J, Mirkovic D, Dabaja BS, Pinnix CC. Rainbow IMRT and Volumetric Imaging for Anterior Mesenteric Targets. Practical Radiation Oncology. PMID 30708131 DOI: 10.1016/J.Prro.2019.01.007  0.708
2019 Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue. Clinical Lymphoma, Myeloma & Leukemia. PMID 30686775 DOI: 10.1016/J.Clml.2018.12.016  0.686
2019 Pinnix CC, Gunther JR, Dabaja BS, Adkins S, Hawkins M, Westin JR, Fayad L, Ahmed S, Fowler NH, Hagemeister FB, Iyer SP, Rodriguez MA, Lee HJ, Steiner RE, Nair R, et al. Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell Lymphoma Blood. 134: 1609-1609. DOI: 10.1182/Blood-2019-131499  0.703
2019 Sano D, Strati P, Alcedo P, Rao VA, Singh P, Miranda RN, Gunther JR, Pinnix CC, Dabaja BS, Lei F, Lee HJ, Steiner RE. Maintenance Rituximab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in the First Line Setting or at Relapse Blood. 134: 5291-5291. DOI: 10.1182/Blood-2019-125980  0.749
2019 Kahn J, Gunther JR, Yang JC, Yahalom J, Dabaja B, Vapiwala N, Hoppe BS, Tseng YD, Parikh RR, Plastaras JP. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Amongst Radiation Oncology Residents International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.517  0.57
2019 Augustyn A, Gunther JR, Medeiros LJ, Milgrom SA, Nastoupil L, Neelapu SS, Nair R, Li S, Ok CY, Steiner RE, Iyer SP, Ahmed S, Westin J, Rodriguez MA, Pasalic D, ... ... Dabaja B, et al. Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.368  0.713
2019 Noticewala S, Gunther J, Dabaja B, Milgrom S, Anakwenze C, Smith G, Yehia Z, Pinnix C. Dosimetric Lung Constraints and Neutrophil-Lymphocyte Ratio as Predictors of Radiation Pneumonitis in Lymphoma Patients treated with Mediastinal IMRT International Journal of Radiation Oncology*Biology*Physics. 105: S246. DOI: 10.1016/J.Ijrobp.2019.06.363  0.71
2019 Ning M, Das P, Klopp A, Gomez D, Allen P, Wells R, Nitsch P, Natter R, Briere T, Herman J, Dabaja B, Koong A, McAleer M. Patterns of 30-Day Post- and on-Treatment Mortality of Patients Undergoing Radiation at a Large Academic Cancer Center: Improving the Quality of Palliative Care International Journal of Radiation Oncology*Biology*Physics. 105: S154. DOI: 10.1016/J.Ijrobp.2019.06.164  0.319
2019 Glober G, Gunther JR, Milgrom SA, Korivi BR, Jensen CT, Wagner-Bartak NA, Lee H, Ahmed S, Nair R, Steiner RE, Iyer SP, Westin J, Fayad L, Rodriguez MA, Neelapu SS, ... ... Dabaja B, et al. Limited Utility of PET-CT and CT Imaging Beyond Treatment Completion in Limited Stage Hodgkin Lymphoma Patients International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1457  0.67
2019 Anakwenze CP, Gunther JR, Manasanch EE, Noticewala SS, Milgrom SA, Lee H, Patel K, Thomas S, Iyer SP, Weber D, Park C, Amini B, Khoury J, Medeiros LJ, Orlowski R, ... Dabaja B, et al. The Impact of PET-CT on Rates of Progression from Solitary Plasmacytoma to Multiple Myeloma after Definitive Radiation Therapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1368  0.7
2019 Pinnix C, Milgrom S, Gunther J, Nastoupil L, Dabaja B. The Management of Primary Mediastinal B Cell Lymphoma Refractory to Dose-Adjusted R-EPOCH alone International Journal of Radiation Oncology*Biology*Physics. 103: 1016. DOI: 10.1016/J.Ijrobp.2018.11.056  0.698
2019 Strati P, Alcedo Andreade P, Sano D, Rao V, Singh P, Miranda R, Gunther J, Pinnix C, Dabaja B, Lee H, Steiner R. RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER Hematological Oncology. 37: 500-500. DOI: 10.1002/Hon.182_2631  0.694
2019 Dabaja B, Gule-Monroe M, Gunther J, Milgrom S, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Nastoupil L, Neelapu S, Pinnix C, Fowler N. DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME? Hematological Oncology. 37: 442-443. DOI: 10.1002/HON.118_2631  0.512
2018 Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA. Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms. Oncotargets and Therapy. 11: 8937-8942. PMID 30573980 DOI: 10.2147/Ott.S159843  0.669
2018 Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez C, Dabaja BS, Duvic M. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatric Dermatology. PMID 30548331 DOI: 10.1111/Pde.13728  0.423
2018 Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SA. Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement. Case Reports in Oncology. 11: 721-728. PMID 30519174 DOI: 10.1159/000494081  0.758
2018 Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Krog Vistisen A, Andraos TY, Ng AK, ... ... Dabaja B, et al. Definitive radiotherapy for localized follicular lymphoma staged by F-FDG PET-CT: a collaborative study by ILROG. Blood. PMID 30446493 DOI: 10.1182/Blood-2018-04-843540  0.415
2018 Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, ... ... Dabaja B, et al. Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Advances in Radiation Oncology. 3: 639-646. PMID 30370365 DOI: 10.1016/J.Adro.2018.07.001  0.773
2018 Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, ... ... Dabaja BS, et al. Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. Clinical Lymphoma, Myeloma & Leukemia. PMID 30360985 DOI: 10.1016/J.Clml.2018.09.002  0.756
2018 Dabaja BS, Specht L, Yahalom J. Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology, Biology, Physics. 102: 508-514. PMID 30238900 DOI: 10.1016/J.Ijrobp.2018.05.078  0.482
2018 Dabaja BS. Successful role of radiation therapy: Account for every single gray and make every single gray count. Best Practice & Research. Clinical Haematology. 31: 217-232. PMID 30213391 DOI: 10.1016/J.Beha.2018.07.009  0.512
2018 Pinnix CC, Huo J, Milgrom SA, Yehia ZA, Fanale M, Oki Y, Dabaja BS, Smith GL. Using benchmarked lung radiation dose constraints to predict pneumonitis risk: Developing a nomogram for patients with mediastinal lymphoma. Advances in Radiation Oncology. 3: 372-381. PMID 30202805 DOI: 10.1016/J.Adro.2018.03.005  0.603
2018 Bakst RL, Dabaja BS, Specht LK, Yahalom J. Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 102: 314-319. PMID 30191865 DOI: 10.1016/J.Ijrobp.2018.05.045  0.495
2018 Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampour S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J. PROTON THERAPY FOR ADULTS WITH MEDIASTINAL LYMPHOMAS: THE INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY GROUP (ILROG) GUIDELINES. Blood. PMID 30108066 DOI: 10.1182/Blood-2018-03-837633  0.497
2018 Pinnix CC, Yahalom J, Specht L, Dabaja BS. Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 102: 53-58. PMID 30102203 DOI: 10.1016/J.Ijrobp.2018.05.067  0.657
2018 Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, et al. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Advances. 2: 1334-1343. PMID 29895624 DOI: 10.1182/Bloodadvances.2018017681  0.717
2018 Wong JYC, Filippi AR, Dabaja BS, Yahalom J, Specht L. Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology, Biology, Physics. 101: 521-529. PMID 29893272 DOI: 10.1016/J.Ijrobp.2018.04.071  0.386
2018 Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, et al. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head & Neck. 40: 1335. PMID 29851218 DOI: 10.1002/Hed.25149  0.593
2018 Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Oki Y, Fayad LE, Medeiros LJ, Dabaja BS, Nastoupil LJ. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure. Leukemia & Lymphoma. 1-8. PMID 29697005 DOI: 10.1080/10428194.2018.1460825  0.739
2018 Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, Thosani S, Wogan C, Conson M, D'Avino V, Oki Y, Fanale M, Lee HJ, Neelapu S, Fayad L, ... ... Dabaja B, et al. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29681481 DOI: 10.1016/J.Ijrobp.2018.03.003  0.753
2018 Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Gunther JR, Fanale MA, Oki Y, Nastoupil L, Chuang HH, Mikhaeel NG, Dabaja BS. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy. Leukemia & Lymphoma. 1-10. PMID 29616834 DOI: 10.1080/10428194.2018.1452211  0.745
2018 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, et al. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 245-254. PMID 29523663 DOI: 10.6004/Jnccn.2018.0013  0.332
2018 Nieto Y, Thall PF, Ma J, Valdez BC, Ahmed S, Anderlini P, Popat U, Jones RB, Shpall EJ, Hosing C, Qazilbash M, Kebriaei P, Alousi A, Timmons M, Gulbis A, ... ... Dabaja B, et al. Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29501779 DOI: 10.1016/J.Bbmt.2018.02.020  0.625
2018 Milgrom SA, Pinnix CC, Chi TL, Vu TH, Gunther JR, Sheu T, Fowler N, Westin JR, Nastoupil LJ, Oki Y, Fayad LE, Neelapu S, Rodriguez MA, Hagemeister FB, Fanale MA, ... ... Dabaja BS, et al. Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29452771 DOI: 10.1016/J.Ijrobp.2018.01.003  0.753
2018 Agbay RLMC, Loghavi S, Zuo Z, Fayad L, Dabaja B, Medeiros LJ, Khoury JD. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma. The American Journal of Surgical Pathology. PMID 29309302 DOI: 10.1097/Pas.0000000000001005  0.372
2018 Brammer JE, Chihara D, Poon LM, Caimi P, de Lima M, Ledesma C, Rondon G, Ciurea SO, Nieto Y, Fanale M, Dabaja B, Maziarz RT, Champlin RE, Hosing C, Oki Y. Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes. Clinical Lymphoma, Myeloma & Leukemia. 18: e41-e50. PMID 29277360 DOI: 10.1016/J.Clml.2017.10.001  0.446
2018 Ludmir E, Milgrom S, Gunther J, Oki Y, Fanale M, Medeiros L, Dabaja B, Pinnix C. Early-Stage Extranodal NK/T-cell Lymphoma: A Role for Elective Nodal Irradiation? International Journal of Radiation Oncology*Biology*Physics. 102: e293-e294. DOI: 10.1016/J.Ijrobp.2018.07.930  0.664
2018 Gunther J, Park C, Milgrom S, Dabaja B, Cruz Chamorro R, Medeiros L, Khoury J, Garg N, Amini B, Fanale M, Lee H, Fowler N, Nastoupil L, Neelapu S, Pinnix C. Radiation Therapy for Salivary Gland MALT Lymphoma: Ultra Low Dose Treatment Spares Salivary Function and Achieves Excellent Outcomes International Journal of Radiation Oncology*Biology*Physics. 102: e244. DOI: 10.1016/J.Ijrobp.2018.07.814  0.735
2018 Gunther J, Pinnix C, Dabaja B, Kebriaei P, Nieto Y, Qiao W, Milgrom S. Peri-Stem Cell Transplant Toxicity after Craniospinal Irradiation: The Influence of Timing International Journal of Radiation Oncology*Biology*Physics. 102: e243-e244. DOI: 10.1016/J.Ijrobp.2018.07.813  0.63
2018 Christopherson KM, Gunther JR, Milgrom SA, Wong PF, Ning MS, Nastoupil L, Neelapu SS, Fowler N, Fanale MA, Westin J, Oki Y, Khoury J, Dabaja B, Pinnix CC. Primary Gastric Diffuse Large B-Cell Lymphoma Treated with Abbreviated Chemoimmunotherapy and Contemporary Radiation Therapy has Excellent Outcomes with Minimal Toxicity International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.706  0.73
2018 Elhammali A, Dabaja B, Gunther J, Yoder A, Moon B, Weber D, Thomas S, Andraos T, Garg N, Amini B, Manasanch E, Patel K, Orlowski R, Lee H, Bird J, et al. Involved Site vs Extended Field Radiation Therapy for Multiple Myeloma of Long Bones after Internal Fixation International Journal of Radiation Oncology*Biology*Physics. 102: e196-e197. DOI: 10.1016/J.Ijrobp.2018.07.705  0.681
2018 Christopherson KM, Gunther JR, Hilal L, Milgrom SA, Pinnix CC, Garg N, Dabaja B. Thirty Year Experience with Rosai Dorfman Disease treated with Radiation, Chemotherapy, and/or Surgery. International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1256  0.685
2018 Ning MS, Milgrom SA, Gunther JR, Pinnix CC, Christopherson KM, Brooks ED, Khoury J, Wang ML, Dabaja B. Low-Dose (4 Gy) Radiation Therapy as an Effective Treatment Modality for Relapsed Refractory Mantle Cell Lymphoma International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1033  0.747
2018 Yoder A, Gunther J, Milgrom S, Nastoupil L, Fanale M, Fowler N, Lee H, Oki Y, Westin J, Neelapu S, Khoury J, Garg N, Amini B, Dabaja B, Pinnix C. Successful Management of Diffuse Large B-Cell Lymphoma Involving the Mesentery with Volumetric Image Guided Intensity Modulated Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: S191. DOI: 10.1016/J.Ijrobp.2018.07.081  0.717
2018 Elhammali A, Gunther J, Milgrom S, Pinnix C, Andraos T, Weber D, Orlowski R, Manasanch E, Patel K, Lee H, Thomas S, Amini B, Garg N, Dabaja B. Involved Site and Reduced Dose Radiation Therapy for Multiple Myeloma: Should It be the New Standard? International Journal of Radiation Oncology*Biology*Physics. 102: S89. DOI: 10.1016/J.Ijrobp.2018.06.232  0.709
2017 Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W, Akhtari M, Allen PK, Atkinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Oki Y, et al. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. British Journal of Haematology. PMID 29271057 DOI: 10.1111/Bjh.15054  0.688
2017 Milgrom SA, Pinnix CC, Gunther JR, Fanale M, Dabaja BS. Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma: response to Adams and Kwee. British Journal of Haematology. PMID 29265334 DOI: 10.1111/Bjh.15072  0.697
2017 Pinnix CC, Andraos TY, Dabaja B, Milgrom S, Smith G, Chihara D, Ng A, Fayad LE, Oki Y, Neelapu S, Westin J, Rodriguez MA, Nastoupil LJ. Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions. Advances in Radiation Oncology. 2: 370-380. PMID 29114605 DOI: 10.1016/J.Adro.2017.04.004  0.67
2017 Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS. Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma. Advances in Radiation Oncology. 2: 363-369. PMID 29114604 DOI: 10.1016/J.Adro.2017.06.004  0.642
2017 Aristophanous M, Chi PM, Kao J, Williamson R, Tung S, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS. Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins. International Journal of Radiation Oncology, Biology, Physics. PMID 29100788 DOI: 10.1016/J.Ijrobp.2017.09.036  0.63
2017 Abaza Y, Kantarjian HM, Faderl S, Jabbour E, Jain N, Thomas D, Kadia T, Borthakur G, Khoury JD, Burger J, Wierda W, O'Brien S, Konopleva M, Ferrajoli A, Kebriaei P, ... Dabaja B, et al. Hyper-CVAD plus Nelarabine in Newly Diagnosed Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma. American Journal of Hematology. PMID 29047158 DOI: 10.1002/Ajh.24947  0.354
2017 Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, ... ... Dabaja BS, et al. Re-classifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood. PMID 29038339 DOI: 10.1182/Blood-2017-04-773838  0.711
2017 Ricardi U, Dabaja B, Hodgson DC. Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 2049-2050. PMID 28911077 DOI: 10.1093/Annonc/Mdx356  0.393
2017 Dabaja BS, Zelenetz AD, Ng AK, Tsang RW, Qi S, Allen PK, Hodgson D, Ricardi U, Hoppe RT, Advani R, Mauch PM, Constine LS, Specht L, Li Y, Terezakis SA, et al. Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 2185-2190. PMID 28911068 DOI: 10.1093/Annonc/Mdx334  0.415
2017 Rechner LA, Maraldo MV, Vogelius IR, Zhu XR, Dabaja BS, Brodin NP, Petersen PM, Specht L, Aznar MC. Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28838605 DOI: 10.1016/J.Radonc.2017.07.033  0.475
2017 Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, ... ... Dabaja BS, et al. Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone? British Journal of Haematology. PMID 28832956 DOI: 10.1111/Bjh.14902  0.729
2017 Li X, Xu-Monette ZY, Yi S, Dabaja BS, Manyam GC, Westin J, Fowler N, Miranda RN, Zhang M, Ferry JA, Medeiros LJ, Harris NL, Young KH. Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center. The American Journal of Surgical Pathology. PMID 28817403 DOI: 10.1097/Pas.0000000000000923  0.358
2017 Lewis DJ, Vin H, Hinojosa T, Tetzlaff MT, Dabaja BS, Duvic M. Primary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report. Journal of Cutaneous Medicine and Surgery. 1203475417721425. PMID 28712310 DOI: 10.1177/1203475417721425  0.425
2017 Gunther JR, Rahman AR, Dong W, Yehia ZA, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Dabaja BS, Smith GL. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment. Practical Radiation Oncology. PMID 28666906 DOI: 10.1016/J.Prro.2017.05.002  0.712
2017 Jabbour E, Daver NG, Short NJ, Huang X, Chen HC, Maiti A, Ravandi F, Cortes J, Abi Aad S, Garcia-Manero G, Estrov Z, Kadia T, O'Brien S, Dabaja B, Bueso-Ramos C, et al. Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia. American Journal of Hematology. PMID 28556489 DOI: 10.1002/Ajh.24799  0.4
2017 Fanale MA, Cheah CY, Rich A, Medeiros LJ, Lai CM, Oki Y, Romaguera JE, Fayad L, Hagemeister FB, Samaniego F, Rodriguez MA, Neelapu SS, Lee HJ, Nastoupil L, Fowler N, ... ... Dabaja B, et al. Encouraging activity for R-CHOP in Advanced Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma. Blood. PMID 28522441 DOI: 10.1182/Blood-2017-02-766121  0.595
2017 Ho JC, Dabaja BS, Milgrom SA, Smith GL, Reddy JP, Mazloom A, Young KH, Deng L, Medeiros LJ, Dong W, Allen PK, Andraos TY, Fowler NH, Nastoupil LJ, Oki Y, et al. Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma(). Leukemia & Lymphoma. 1-12. PMID 28482717 DOI: 10.1080/10428194.2017.1312381  0.671
2017 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, et al. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 608-638. PMID 28476741 DOI: 10.6004/Jnccn.2017.0064  0.408
2017 Jain P, Milgrom SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, Hu S, Bueso Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, et al. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. British Journal of Haematology. PMID 28382648 DOI: 10.1111/Bjh.14672  0.62
2017 Dabaja B. Renaissance of Low-Dose Radiotherapy Concepts for Cutaneous Lymphomas. Oncology Research and Treatment. 40: 255-260. PMID 28380490 DOI: 10.1159/000470845  0.31
2017 Wang H, Milgrom SA, Dabaja BS, Smith GL, Martel M, Pinnix CC. Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma. Practical Radiation Oncology. PMID 28377138 DOI: 10.1016/J.Prro.2017.03.001  0.611
2017 Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, et al. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head & Neck. PMID 28370694 DOI: 10.1002/Hed.24717  0.611
2017 Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, ... ... Dabaja BS, et al. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. International Journal of Radiation Oncology, Biology, Physics. 97: 333-338. PMID 28068241 DOI: 10.1016/J.Ijrobp.2016.10.029  0.687
2017 Manasanch EE, Claussen CM, Dong W, Lee HC, Thomas SK, Patel KK, Reed VK, Dabaja BS, Milgrom S, Pinnix CC, Parmar S, Bashir Q, Qazilbash MH, Amini B, Raymond A, et al. A Clinical Model of Progression to Multiple Myeloma in Solitary Plasmacytoma Blood. 130: 5367-5367. DOI: 10.1182/Blood.V130.Suppl_1.5367.5367  0.59
2017 Rechner L, Maraldo M, Vogelius I, Petersen P, Zhu R, Dabaja B, Brodin N, Specht L, Aznar M. PO-0813: Cardiac Toxicity after Radiotherapy for Hodgkin Lymphoma: Impact of Breath Hold and Proton Therapy Radiotherapy and Oncology. 123: S435. DOI: 10.1016/S0167-8140(17)31250-1  0.417
2017 Andraos TY, Ayoub Z, Nastoupil L, Milgrom SA, Pinnix CC, Ng SP, Fowler N, Neelapu SS, Samaniego F, Fayad L, Dabaja B. Adjuvant Therapy Improves Outcomes in Completely Resected, Limited-Stage Follicular Lymphoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.453  0.577
2017 Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Fanale MA, Oki Y, Nastoupil L, Mikhaeel G, Dabaja B. Omission of Cardiophrenic Lymph Nodes in the Treatment of Patients with Hodgkin Lymphoma Using Modified Involved Site Radiation Therapy: Lower Toxicity with No Added Failure International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.452  0.564
2017 Aristophanous M, Chi PCM, Kao J, Williamson RT, Tung S, Andraos TY, Milgrom SA, Pinnix CC, Dabaja B. Local Uncertainty Variation in DIBH-IMRT Treatments for Mediastinal Lymphoma and the Implications on Setup Margin Selection International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.2132  0.499
2017 Sheu T, Milgrom SA, Dabaja B, Andraos TY, Chi L, Nastoupil L, Fowler N, Westin J, Neelapu SS, Lee H, Hagemeister F, Oki Y, Fanale MA, Fayad L, Turturro F, et al. Poster ViewingConsolidative Radiation Dose De-escalation in Primary CNS Lymphoma for Patients with an Incomplete Response to Methotrexate Based Chemotherapy International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1643  0.621
2017 Milgrom SA, Pinnix CC, Sheu T, Qiao W, Fowler N, Westin J, Nastoupil L, Hagemeister F, Oki Y, Fanale MA, Fayad L, Lee H, Hosing C, Nieto Y, Shpall EJ, ... Dabaja B, et al. Radiation As an Effective Salvage Therapy for Secondary CNS Lymphoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1638  0.623
2017 Ayoub Z, Andraos TY, Pinnix CC, Dabaja B, Nastoupil L, Mawlawi OR, Ng SP, Fowler N, Neelapu SS, Samaniego F, Fayad L, Milgrom SA. Poster ViewingBaseline PET-CT Does Not Predict Outcome in Localized, Low Tumor Burden Follicular Lymphoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1622  0.497
2017 Ayoub Z, Andraos TY, Milgrom SA, Pinnix CC, Dabaja B, Ng SP, Fowler N, Neelapu SS, Samaniego F, Khoury J, Fayad L, Nastoupil L. Grade 3 Follicular Lymphoma Patients Can Experience Favorable Outcomes With Various Management Strategies International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1621  0.519
2017 Andraos TY, Ayoub Z, Pinnix CC, Milgrom SA, Nastoupil L, Ng SP, Fowler N, Neelapu SS, Samaniego F, Fayad L, Dabaja B. Primary Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1620  0.499
2017 An Y, Jiang W, Andraos T, Pinnix C, Milgrom S, Lloyd S, Wilson L, Dabaja B. Circulating CD4:CD8 Ratio is Prognosticator of Response to Total Skin Electron Beam Radiation in Mycoses Fungoides International Journal of Radiation Oncology*Biology*Physics. 99: E424. DOI: 10.1016/J.Ijrobp.2017.06.1618  0.455
2017 Pinnix CC, Andraos TY, Qiao W, Milgrom SA, Cella L, Pacelli R, Nastoupil L, Hagemeister F, Lee H, Fanale MA, Dabaja B. Oral Scientific SessionsPotential to Reduce Toxicity: Clinical and Dosimetric Predictors of Hypothyroidism After Radiation Therapy With IMRT for Hodgkin Lymphoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.157  0.617
2017 Milgrom S, Lee J, Wang Q, Court L, Ng A, Pinnix C, Dabaja B, Akhtari M, Aristophanous M, Mawlawi O, Andraos T, Lee H, Hagemeister F, Oki Y, Fanale M, et al. Importance of PET-CT Radiomics Features in Outcomes Prognostication for Mediastinal Hodgkin Lymphoma International Journal of Radiation Oncology*Biology*Physics. 99: S63. DOI: 10.1016/J.Ijrobp.2017.06.156  0.514
2017 Milgrom S, Chi P, Pinnix C, Aristophanous M, Umfleet W, Hancock D, Pham M, Melkun M, Garcia J, Dabaja B. Rainbows and Butterflies: Individualized IMRT Planning for Mediastinal Lymphoma International Journal of Radiation Oncology*Biology*Physics. 99: S61. DOI: 10.1016/J.Ijrobp.2017.06.152  0.501
2017 Moreno AC, Dabaja B, Milgrom SA, Andraos TY, Oyervides M, Williamson T, Pinnix CC. Dosimetric Comparison of Intensity-Modulated Radiation Therapy via Breath Hold Technique and Proton Therapy With or Without Breath Hold for Mediastinal Lymphoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.151  0.585
2017 Nieto Y, Bassett R, Ahmed S, Anderlini P, Hosing CM, Popat UR, Andersson BS, Valdez BC, Shpall EJ, Qazilbash MH, Kebriaei P, Alousi AM, Guillermo M, Oki Y, Fanale MA, ... ... Dabaja B, et al. Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem Cell Transplant (ASCT) in Hodgkin's Lymphoma Patients at High Risk of Post-Transplant Recurrence—Comparison with a Concurrent Matched Cohort Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.432  0.561
2016 Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, et al. ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology (Williston Park, N.Y.). 30. PMID 27987203  0.3
2016 Milgrom SA, Jauhari S, Plastaras JP, Nieto Y, Dabaja BS, Pinnix CC, Smith GL, Allen PK, Lukens JN, Maity A, Oki Y, Fanale MA, Nasta SD. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. Cancer. PMID 27984652 DOI: 10.1002/Cncr.30482  0.602
2016 Zhou R, Liao Z, Pan T, Milgrom SA, Pinnix CC, Shi A, Tang L, Yang J, Liu Y, Gomez D, Nguyen QN, Dabaja BS, Court L, Yang J. Cardiac atlas development and validation for automatic segmentation of cardiac substructures. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27939201 DOI: 10.1016/J.Radonc.2016.11.016  0.457
2016 Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya C, Woodman K, Dinardo C, Jain N, Kadia TM, ... ... Dabaja BS, et al. Dorsal Column Myelopathy after Intrathecal Chemotherapy for Leukemia. American Journal of Hematology. PMID 27874212 DOI: 10.1002/Ajh.24611  0.578
2016 Ahmed M, Li L, Pinnix C, Dabaja B, Nomie K, Lam L, Wang M. ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma. Critical Reviews in Oncology/Hematology. 107: 14-19. PMID 27823642 DOI: 10.1016/J.Critrevonc.2016.08.008  0.565
2016 Abou Yehia Z, Mikhaeel GN, Smith G, Pinnix CC, Milgrom SA, Tang C, Jiang W, Fanale MA, Oki Y, Shank JH, Horace T, Reddy J, Akhtari M, Gunther JR, Suki T, ... ... Dabaja BS, et al. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma? International Journal of Radiation Oncology, Biology, Physics. PMID 27742539 DOI: 10.1016/J.Ijrobp.2016.08.018  0.753
2016 Akhtari M, Reddy J, Dong W, Milgrom SA, Smith GL, Pinnix CC, Yehia ZA, Gunther JR, Osborne EM, Mawlawi OR, Rohren EM, Chuang HH, Garg N, Fanale M, Dabaja B. Restratifying Early-Stage Hodgkin Lymphoma Patients Using Novel Functional Imaging Parameters. International Journal of Radiation Oncology, Biology, Physics. 96: S40. PMID 27675923 DOI: 10.1016/J.Ijrobp.2016.06.109  0.691
2016 Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi OR, Rohren EM, Garg N, Chuang HH, Yehia ZA, Reddy J, Gunther JR, Osborne EM, Oki Y, Fanale M, ... Dabaja B, et al. Postchemotherapy Positron Emission Tomography/Computed Tomography Scans in Early-Stage Hodgkin Lymphoma: Moving Beyond the Deauville 5-Point Scale. International Journal of Radiation Oncology, Biology, Physics. 96: S40-S41. PMID 27675922 DOI: 10.1016/J.Ijrobp.2016.06.110  0.674
2016 Smith GL, Duvic M, Yehia ZA, Allen PK, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Dabaja B. Effectiveness of Very Low- and Low-Dose Radiation for Primary Cutaneous Anaplastic Large Cell Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 96: S38-S39. PMID 27675916 DOI: 10.1016/J.Ijrobp.2016.06.105  0.583
2016 Reddy J, Gunther JR, Dabaja B, Akhtari M, Martin GV, Allen PK, Aktinson BJ, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Osborne EM, Fanale M. Pretreatment Neutrophil/Lymphocyte Ratio Predicts Relapse in Stage I and II Hodgkin Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 96: S22-S23. PMID 27675828 DOI: 10.1016/J.Ijrobp.2016.06.067  0.689
2016 Jiang W, Abou Yehia Z, Dabaja B, Duvic M, Milgrom SA, Pinnix CC, Oki Y, D'Souza N, Smith GL. CD4:CD8 Ratio in Mycosis Fungoides: Prognostic and Predictive Value of Circulating T Lymphocyte Subsets for Outcomes After Total Skin Electron Beam Radiation. International Journal of Radiation Oncology, Biology, Physics. 96: S20. PMID 27675777 DOI: 10.1016/J.Ijrobp.2016.06.061  0.471
2016 Ho JC, Reddy J, Mazloom A, Allen PK, Milgrom SA, Smith GL, Medeiros LJ, Young KH, Fowler NH, Dabaja B, Pinnix CC. Radiation Therapy Improves Outcomes in Patients With Primary Testicular Diffuse Large B-cell Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 96: S20. PMID 27675776 DOI: 10.1016/J.Ijrobp.2016.06.062  0.671
2016 Pinnix CC, Yehia ZA, Qiao W, Milgrom SA, Smith GL, Akhtari M, Reddy J, Gunther JR, Osborne EM, Mawlawi OR, Medeiros LJ, Garg N, Chuang HH, Neelapu S, Westin JR, ... Dabaja B, et al. Utilization of Positron Emission Tomography/Computed Tomography Parameters to Identify Patients at Risk for Progression After Treatment With Dose-Adjusted R-EPOCH for Primary Mediastinal B-Cell Lymphoma (PMBCL). International Journal of Radiation Oncology, Biology, Physics. 96: S20-S21. PMID 27675775 DOI: 10.1016/J.Ijrobp.2016.06.063  0.712
2016 Milgrom SA, Smith GL, Pinnix CC, Dong W, Akhtari M, Mawlawi OR, Rohren EM, Garg N, Chuang HH, Reddy J, Gunther JR, Osborne EM, Yehia ZA, Oki Y, Fanale M, ... Dabaja B, et al. Prognostic Significance of the Postchemotherapy Positron Emission Tomography (PET)/Computed Tomography in Early-Stage Hodgkin Lymphoma: Can PET-Positive Patients Be Cured With Radiation Alone? International Journal of Radiation Oncology, Biology, Physics. 96: S167. PMID 27675690 DOI: 10.1016/J.Ijrobp.2016.06.421  0.705
2016 Abou Yehia Z, Dabaja B, Smith GL, Milgrom SA, Kantarjian H, Allen PK, Garg N, Pierce SA, Reddy J, Mawlawi OR, Suki T, Medeiros LJ, Jabbour E, Jain N, Pinnix CC. Effectiveness of Radiation Treatment in Adult Patients With Mediastinal T Cell Lymphoblastic Leukemia/Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 96: S165. PMID 27675685 DOI: 10.1016/J.Ijrobp.2016.06.416  0.625
2016 Smith GL, Rahman AR, Dong W, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Dabaja B. Proton Versus Photon Craniospinal Irradiation for Hematologic Malignancies Involving the CNS: Effectiveness and Toxicity in the Setting of Stem Cell Transplant. International Journal of Radiation Oncology, Biology, Physics. 96: E496. PMID 27674846 DOI: 10.1016/J.Ijrobp.2016.06.1874  0.54
2016 Milgrom SA, Jauhari S, Plastaras JP, Lukens JN, Nieto Y, Dabaja B, Smith GL, Pinnix CC, Maity A, Nasta S. A Multi-institutional Analysis of Consolidative Radiation Therapy Following Autologous Transplantation for Relapsed/Refractory Hodgkin Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 96: E495-E496. PMID 27674842 DOI: 10.1016/J.Ijrobp.2016.06.1872  0.649
2016 Milgrom SA, Cheah C, Pinnix CC, Smith GL, Dabaja B, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS. Acute and Late Toxicity of Bilateral Orbital Irradiation in the Management of Primary Intraocular Lymphoma. International Journal of Radiation Oncology, Biology, Physics. 96: E490. PMID 27674830 DOI: 10.1016/J.Ijrobp.2016.06.1859  0.555
2016 Pinnix CC, Abou Yehia Z, Smith GL, Milgrom SA, Ho JC, Reddy J, Gunther JR, Akhtari M, Osborne EM, Medeiros LJ, Fanale M, Dabaja B. More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone. International Journal of Radiation Oncology, Biology, Physics. 96: E489-E490. PMID 27674825 DOI: 10.1016/J.Ijrobp.2016.06.1858  0.765
2016 Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, et al. ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. American Journal of Clinical Oncology. PMID 27643717 DOI: 10.1097/Coc.0000000000000331  0.458
2016 Milgrom SA, Nieto Y, Pinnix CC, Smith GL, Wogan CF, Rondon G, Medeiros LJ, Kebriaei P, Dabaja BS. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports. Journal of Medical Case Reports. 10: 209. PMID 27465468 DOI: 10.1186/S13256-016-0999-Z  0.614
2016 Haque W, Dabaja B, Tann A, Khan M, Szeja S, Butler EB, Teh BS. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27373911 DOI: 10.1016/J.Radonc.2016.05.027  0.473
2016 Gunther JR, Fanale MA, Reddy JP, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Allen PK, Osborne EM, Mawlawi O, Dabaja BS. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. International Journal of Radiation Oncology, Biology, Physics. PMID 27325479 DOI: 10.1016/J.Ijrobp.2016.03.052  0.776
2016 Million L, Yi EJ, Wu F, Von Eyben R, Campbell BA, Dabaja B, Tsang RW, Ng A, Wilson LD, Ricardi U, Kirova Y, Hoppe RT. Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience. International Journal of Radiation Oncology, Biology, Physics. PMID 27315663 DOI: 10.1016/J.Ijrobp.2016.03.023  0.509
2016 Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, et al. ACR Appropriateness Criteria Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. American Journal of Clinical Oncology. PMID 27299425 DOI: 10.1097/Coc.0000000000000294  0.426
2016 Pinnix CC, Osborne EM, Chihara D, Lai P, Zhou S, Ramirez MM, Oki Y, Hagemeister FB, Rodriguez AM, Samaniego F, Fowler N, Romaguera JE, Turturro F, Fayad L, Westin JR, ... ... Dabaja BS, et al. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy. Jama Oncology. PMID 27227654 DOI: 10.1001/Jamaoncol.2016.1396  0.562
2016 Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz A, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, ... Dabaja B, et al. Clinical characteristics and outcomes of patients with hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. American Journal of Hematology. PMID 27222367 DOI: 10.1182/Blood.V126.23.3865.3865  0.647
2016 Nieto Y, Valdez BC, Thall PF, Jones RB, Wei W, Myers A, Hosing C, Ahmed S, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Shah N, Bashir Q, ... ... Dabaja B, et al. Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma. Cancer. PMID 27203405 DOI: 10.1002/Cncr.30100  0.595
2016 Dabaja BS, Mikhaeel NG. In the Battle Between Protons and Photons for Hematologic Malignancies, the Patient Must Win. International Journal of Radiation Oncology, Biology, Physics. 95: 43-45. PMID 27084623 DOI: 10.1016/J.Ijrobp.2015.09.043  0.31
2016 Milgrom SA, Cheah CY, Pinnix CC, Smith GL, Dabaja BS, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS. Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma. Leukemia & Lymphoma. 1-7. PMID 27075636 DOI: 10.3109/10428194.2016.1166490  0.617
2016 Sathyanarayanan V, Chihara D, Fanale MA, Costelloe CM, Ghonimi E, Shen C, Vega F, Dabaja BS, Oki Y, Zhou S, Hubert C. Prognostic value of PET-CT in early stage Hodgkin Lymphoma (HL) using updated 5 point scoring system. Journal of Clinical Oncology. 34: e19013-e19013. DOI: 10.1200/Jco.2016.34.15_Suppl.E19013  0.315
2015 Pinnix CC, Shah JJ, Chuang H, Costelloe CM, Medeiros LJ, Wogan CF, Reed V, Smith GL, Milgrom S, Patel K, Huo J, Turturro F, Romaguera J, Fayad L, Oki Y, ... ... Dabaja B, et al. Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clinical Lymphoma, Myeloma & Leukemia. PMID 26795083 DOI: 10.1016/J.Clml.2015.12.008  0.677
2015 Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, et al. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. American Journal of Clinical Oncology. 38: 610-20. PMID 26583344 DOI: 10.1097/Coc.0000000000000215  0.451
2015 Xu-Monette ZY, Dabaja BS, Wang X, Tu M, Manyam GC, Tzankov A, Xia Y, Zhang L, Sun R, Visco C, Dybkaer K, Yin L, Chiu A, Orazi A, Zu Y, et al. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26541272 DOI: 10.1038/Modpathol.2015.118  0.363
2015 Cheah CY, Milgrom S, Chihara D, Gombos DS, Pinnix CC, Dabaja BS, Fowler NH. Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro-Oncology. PMID 26487691 DOI: 10.1093/Neuonc/Nov253  0.631
2015 Brown DN, Wieser I, Wang C, Dabaja BS, Duvic M. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature. Journal of the American Academy of Dermatology. PMID 26476898 DOI: 10.1016/J.Jaad.2015.09.017  0.442
2015 Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, et al. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26416896 DOI: 10.1093/Annonc/Mdv473  0.587
2015 Youssef B, Shank J, Reddy JP, Pinnix CC, Farha G, Akhtari M, Allen PK, Fanale MA, Garcia JA, Horace PH, Milgrom S, Smith GL, Nieto Y, Arzu I, Wang H, ... ... Dabaja B, et al. Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma. Radiation Oncology (London, England). 10: 206. PMID 26407853 DOI: 10.1186/S13014-015-0504-7  0.68
2015 Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease. Clinical Lymphoma, Myeloma & Leukemia. PMID 26321471 DOI: 10.1016/J.Clml.2015.07.633  0.763
2015 Zhou R, Yang J, Pan T, Milgrom S, Pinnix C, Shi A, Yang J, Liu Y, Nguyen Q, Gomez D, Dabaja B, Balter P, Court L, Liao Z. SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation. Medical Physics. 42: 3294. PMID 26127520 DOI: 10.1118/1.4924215  0.514
2015 Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Alousi A, Shah N, Bashir Q, Liu Y, ... ... Dabaja B, et al. Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26071868 DOI: 10.1016/J.Bbmt.2015.06.003  0.599
2015 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, et al. Hodgkin lymphoma, version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 554-86. PMID 25964641 DOI: 10.6004/Jnccn.2015.0075  0.429
2015 Pinnix CC, Smith GL, Milgrom S, Osborne EM, Reddy JP, Akhtari M, Reed V, Arzu I, Allen PK, Wogan CF, Fanale MA, Oki Y, Turturro F, Romaguera J, Fayad L, ... ... Dabaja B, et al. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma. International Journal of Radiation Oncology, Biology, Physics. 92: 175-82. PMID 25863764 DOI: 10.1016/J.Ijrobp.2015.02.010  0.691
2015 Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe C, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, et al. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. International Journal of Radiation Oncology, Biology, Physics. 92: 113-21. PMID 25863759 DOI: 10.1016/J.Ijrobp.2015.02.006  0.636
2015 Specht L, Dabaja B, Illidge T, Wilson LD, Hoppe RT. Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 92: 32-9. PMID 25863751 DOI: 10.1016/J.Ijrobp.2015.01.008  0.505
2015 Akhtari M, Reddy JP, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leukemia & Lymphoma. 1-5. PMID 25860237 DOI: 10.3109/10428194.2015.1040012  0.772
2015 Tao R, Allen PK, Rodriguez A, Shihadeh F, Pinnix CC, Arzu I, Reed VK, Oki Y, Westin JR, Fayad LE, Medeiros LJ, Dabaja B. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. International Journal of Radiation Oncology, Biology, Physics. 92: 122-9. PMID 25754633 DOI: 10.1016/J.Ijrobp.2015.01.014  0.677
2015 Maraldo MV, Dabaja BS, Filippi AR, Illidge T, Tsang R, Ricardi U, Petersen PM, Schut DA, Garcia J, Headley J, Parent A, Guibord B, Ragona R, Specht L. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 92: 144-52. PMID 25670544 DOI: 10.1016/J.Ijrobp.2014.12.009  0.503
2015 Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Cancer. 121: 1032-9. PMID 25492236 DOI: 10.1002/Cncr.29113  0.404
2015 Hoppe RT, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Gangar P, Duvic M, Kim YH. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. Journal of the American Academy of Dermatology. 72: 286-92. PMID 25476993 DOI: 10.1016/J.Jaad.2014.10.014  0.376
2015 Nieto Y, Bassett R, Anderlini P, Hosing CM, Alousi AM, Popat UR, Andersson BS, Valdez BC, Shpall EJ, Ahmed S, Qazilbash M, Guillermo M, Oki Y, Fanale MA, Hagemeister FB, ... Dabaja BS, et al. Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM Blood. 126: 1980-1980. DOI: 10.1182/Blood.V126.23.1980.1980  0.577
2015 Abou Yehia ZA, Mikhaeel G, Smith G, Pinnix CC, Milgrom SA, Fanale MA, Reddy J, Osborne E, Akhtari M, Gunther J, Allen P, Dabaja BS. Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients Blood. 126: 1511-1511. DOI: 10.1182/Blood.V126.23.1511.1511  0.771
2015 Pinnix C, Dabaja B, Milgrom S, Smith G, Reed V, Arzu I, Westin J, Rondon G, Hosing C, Nieto Y, Ahmed S. Salvage Radiation Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma International Journal of Radiation Oncology*Biology*Physics. 93: E459-E460. DOI: 10.1016/J.Ijrobp.2015.07.1719  0.62
2015 Pinnix C, Esmaeli B, Smith G, Milgrom S, Reed V, Arzu I, Shank J, Horace P, Allen K, Turner S, Morrell G, Fowler N, Dabaja B. Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa International Journal of Radiation Oncology*Biology*Physics. 93: E459. DOI: 10.1016/J.Ijrobp.2015.07.1718  0.658
2015 Milgrom S, Nieto Y, Pinnix C, Smith G, Reed V, Kebriaei P, Dabaja B. Graft-Versus-Host Disease Following Radiation Therapy in Patients With a History of Allogeneic Stem Cell Transplant International Journal of Radiation Oncology*Biology*Physics. 93: E457. DOI: 10.1016/J.Ijrobp.2015.07.1714  0.593
2015 Abou Yehia Z, Tang C, Milgrom S, Fanale M, Smith G, Pinnix C, Reddy J, Akhtari M, Gunther J, Osborne E, Ahmed S, Dabaja B. Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma International Journal of Radiation Oncology*Biology*Physics. 93: E456. DOI: 10.1016/J.Ijrobp.2015.07.1711  0.681
2015 Akhtari M, Reddy J, Pinnix C, Allen P, Osborne E, Gunther J, Milgrom S, Smith G, Wogan C, Fowler N, Rodriguez M, Dabaja B. Excellent Outcomes in Primary Cutaneous B-cell Lymphoma After Very Low Dose Radiation International Journal of Radiation Oncology*Biology*Physics. 93: E448. DOI: 10.1016/J.Ijrobp.2015.07.1690  0.741
2015 Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease Clinical Lymphoma, Myeloma and Leukemia. DOI: 10.1016/j.clml.2015.07.633  0.736
2015 Manasanch E, Claussen C, Dong W, Shah J, Lee H, Thomas S, Reed V, Dabaja B, Milgrom S, Pinnix C, Parmar S, Shah N, Patel K, Bashir Q, Qazilbash M, et al. Clinical characteristics, outcomes and predictors of progression to multiple myeloma (MM) in 61 patients with solitary plasmacytoma Clinical Lymphoma Myeloma and Leukemia. 15: e181-e182. DOI: 10.1016/J.Clml.2015.07.407  0.571
2015 Richards T, Shah J, Horowitz S, Shah R, Comer J, Yu J, Feng L, Sevin A, Dabaja B, Pinnix C, Milgrom S, Reed V, Manasanch E, Thomas S, Shah N, et al. Characteristics of Myeloma (MM) Patients (pts) with Central Nervous System (CNS) Involvement Clinical Lymphoma Myeloma and Leukemia. 15: e117-e118. DOI: 10.1016/J.Clml.2015.07.302  0.482
2015 Polansky M, Daulat S, Talpur R, Hosing C, Dabaja B, Duvic M. Long-Term Complete Responses to Combination Therapies and Allogenic Stem Cell Transplants in Sézary Patients Clinical Lymphoma Myeloma and Leukemia. 15: S227-S228. DOI: 10.1016/J.Clml.2015.04.108  0.347
2014 Chi P, Pinnix C, Dabaja B, Wang C, Aristophanous M, Tung S. SU-E-T-404: Simple Field-In-Field Technique for Total Body Irradiation in Large Patients. Medical Physics. 41: 318. PMID 28037432 DOI: 10.1118/1.4888737  0.519
2014 Aristophanous M, Chi P, Tung S, Pinnix C, Dabaja B. SU-E-T-522: A Multi-Isocenter VMAT Technique for Cranio-Spinal Irradiation. Medical Physics. 41: 347. PMID 28036894 DOI: 10.1118/1.4888855  0.505
2014 Walker GV, Shihadeh F, Kantarjian H, Allen P, Rondon G, Kebriaei P, O'Brien S, Kedir A, Said M, Grant JD, Thomas DA, Gidley PW, Arzu I, Pinnix C, Reed V, ... Dabaja BS, et al. Comprehensive craniospinal radiation for controlling central nervous system leukemia. International Journal of Radiation Oncology, Biology, Physics. 90: 1119-25. PMID 25539370 DOI: 10.1016/J.Ijrobp.2014.08.004  0.593
2014 Polansky M, Talpur R, Daulat S, Hosing C, Dabaja B, Duvic M. Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome. Clinical Lymphoma, Myeloma & Leukemia. 15: e83-93. PMID 25458083 DOI: 10.1016/J.Clml.2014.09.013  0.374
2014 Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, et al. ACR appropriateness criteria follow-up of Hodgkin lymphoma. Journal of the American College of Radiology : Jacr. 11: 1026-1033.e3. PMID 25278496 DOI: 10.1016/J.Jacr.2014.07.038  0.392
2014 Haque W, Voong KR, Shihadeh F, Arzu I, Pinnix C, Mazloom A, Medeiros LJ, Romaguera J, Rodriguez A, Wang M, Allen P, Dabaja B. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients Clinical Lymphoma, Myeloma and Leukemia. 14: 474-479. PMID 25108680 DOI: 10.1016/J.Clml.2014.07.003  0.671
2014 Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, Ram R, Dabaja B, Rondon G, Champlin R, Sandmaier BM, Doney K, Bar M, Kebriaei P. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1767-71. PMID 25017763 DOI: 10.1016/J.Bbmt.2014.07.005  0.337
2014 Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, ... Dabaja BS, et al. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. British Journal of Haematology. 166: 891-901. PMID 24943107 DOI: 10.1111/Bjh.12982  0.629
2014 Voong KR, McSpadden K, Pinnix CC, Shihadeh F, Reed V, Salehpour MR, Arzu I, Wang H, Hodgson D, Garcia J, Aristophanous M, Dabaja BS. Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma. Radiation Oncology (London, England). 9: 94. PMID 24735767 DOI: 10.1186/1748-717X-9-94  0.655
2014 Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A, Ricardi U, Wirth A. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 89: 49-58. PMID 24725689 DOI: 10.1016/J.Ijrobp.2014.01.006  0.473
2014 Dabaja BS, Hess K, Shihadeh F, Podoloff DA, Medeiros LJ, Mawlawi O, Arzu I, Oki Y, Hagemeister FB, Fayad LE, Reed VK, Kedir A, Wogan CF, Rodriguez A. Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation. International Journal of Radiation Oncology, Biology, Physics. 89: 384-91. PMID 24721592 DOI: 10.1016/J.Ijrobp.2014.02.015  0.516
2014 Kim MM, Dabaja BS, Medeiros J, Kim S, Allen P, Chevez-Barrios P, Gombos DS, Fowler N. Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution Experience. American Journal of Clinical Oncology. PMID 24390272 DOI: 10.1097/Coc.0000000000000028  0.392
2014 Oki Y, Chuang H, Chasen B, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, et al. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. British Journal of Haematology. 165: 112-6. PMID 24386943 DOI: 10.1111/Bjh.12715  0.359
2014 Loghavi S, Xu-Monette ZY, Fayad L, Kwak LW, Dabaja BS, Medeiros LJ, Young KH. Clinical and Biological Features of Primary Testicular B-Cell Lymphoma - a Single-Institution Study of 89 Cases Blood. 124: 3036-3036. DOI: 10.1182/Blood.V124.21.3036.3036  0.515
2014 Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera JE, Fayad L, Rodriguez MA, Samaniego F, Fowler N, Oki Y, Turturro F, Westin JR, Kwak LW, Dabaja BS, et al. Antibiotic Therapy of H. Pylori Negative Gastric MALT Lymphoma Blood. 124: 1735-1735. DOI: 10.1182/Blood.V124.21.1735.1735  0.432
2014 Dabaja B, Tsang R, Qi S, Allen P, Hodgson D, Ricardi U, Hoppe R, Ng A, Mauch P, Specht L, Li Y, Terezakis S, Wirth A, Reinartz G, Eich H, et al. Favorable Outcome in Stage I-II Mantle Cell Lymphoma: A Report of 160 Patients From the International Lymphoma Radiation Oncology Group (ILROG) International Journal of Radiation Oncology*Biology*Physics. 90: S151-S152. DOI: 10.1016/J.Ijrobp.2014.05.629  0.391
2014 Hoppe R, Harrison C, Tavallaee M, Bashey S, Li S, Million L, Dabaja B, Duvic M, Kim Y. Low Dose (12 Gy) Total Skin Electron Beam Therapy (TSEBT) for Mycosis Fungoides (mf): Results of Three Phase 2 Clinical Trials International Journal of Radiation Oncology*Biology*Physics. 90: S151. DOI: 10.1016/J.Ijrobp.2014.05.628  0.323
2014 Pinnix C, Westin J, Ahmed M, Reed V, Romaguerra J, Oki Y, Rodriguez M, Fayad L, Hagemeister F, Kwak L, Medeiros L, Francesco T, Davis R, Chuang H, Davis R, ... Dabaja B, et al. The Role of Radiation Therapy in the Treatment of Primary Mediastinal B Cell Lymphoma Treated with Rituximab containing Regimens International Journal of Radiation Oncology*Biology*Physics. 90: S68-S69. DOI: 10.1016/J.Ijrobp.2014.05.2673  0.67
2014 Tao R, Shihadeh F, Pinnix CC, Arzu I, Reed V, Oki Y, Westin J, Fayad L, Medeiros L, Rodriguez A, Dabaja B. Does Skeletal Presentation Make a Difference in Outcomes of Diffuse Large B-cell Lymphoma? A Review of the 25-Year Experience With Treating Primary Bone Lymphoma International Journal of Radiation Oncology Biology Physics. 90: 66-67. DOI: 10.1016/J.Ijrobp.2014.05.224  0.587
2014 Dabaja B, Shihadeh F, Rodriguez M, Etzel C, Liang F, Shirvani SM, Ballas LK, Allen P, Fanale M, Wogan C, Younes A, Oki Y. Improvements in Treatments for Hodgkin Lymphoma Over a 50-Year Period Lead to Fewer Second Malignancies International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.222  0.354
2014 Pinnix CC, Patel K, Reed V, Oki Y, Qazilbash M, Muzzafar T, Weber D, Fowler N, Popat U, Fanale M, Nieto Y, Shah N, Bashir Q, Hagemeister F, Orlowski R, ... ... Dabaja B, et al. The Outcome of Limited-Stage Plasmablastic Lymphoma Treated With and Without Radiation Therapy: A Single-Institutional Experience International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1992  0.677
2014 Dabaja B, Shihadeh F, Arzu I, Pinnix C, Allen P, Nastoupil L, Oki Y, Medeiros L, Rodriguez M, Fowler N. Follicular Lymphoma of the Skin: Different Therapies Similar Outcome International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1986  0.591
2014 Dabaja B, Pinnix CC, Fowler N, Allen P, Reed V, Ballas LK, Horace P, Rodriguez M, Nastoupil L, Kwak L, Medeiros L, Arzu I, Ha CS. Definitive Radiation Therapy for Stage I and II Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma: Report of a Prospective Study International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1985  0.612
2014 Dabaja B, Shank J, Pinnix CC, Wang HC, Garcia J, fanale M, Oki Y, Nieto Y, Arzu I, Horace P, Rodriguez M. Hodgkin Lymphoma Treatment: Modern Radiation Therapy, Lower Dose, Smaller Field, But the Risk of Lhermitte Sign Is Still There International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1974  0.65
2013 Wang H, Tung S, Wang C, Mahajan A, Dabaja B, Martel M. SU-E-T-592: Investigation of Volumetric Modulated Arc Therapy for Total Body Irradiation with Lung Blocks. Medical Physics. 40: 341. PMID 28519085 DOI: 10.1118/1.4815020  0.322
2013 Court L, Yang J, Fullen D, Han N, Ko J, Mason S, Nguyen K, Stein S, Fave X, Hsieh M, Kuruvila S, Hillebrandt E, Palmer J, Beadle B, Dabaja B, et al. SU-E-T-359: Patients Could (and Should) Be Treated in An Upright Position. Medical Physics. 40: 287. PMID 28517771 DOI: 10.1118/1.4814793  0.315
2013 Wang CM, Duvic M, Dabaja BS. Acral erosive mycosis fungoides: successful treatment with localised radiotherapy. Bmj Case Reports. 2013. PMID 23595169 DOI: 10.1136/Bcr-2012-007120  0.419
2013 Dabaja BS, Phan J, Mawlawi O, Medeiros LJ, Etzel C, Liang FW, Podoloff D, Oki Y, Hagemeister FB, Chuang H, Fayad LE, Westin JR, Shihadeh F, Allen PK, Wogan CF, et al. Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma. Leukemia & Lymphoma. 54: 2631-8. PMID 23488661 DOI: 10.3109/10428194.2013.784967  0.39
2013 Xu-Monette ZY, Dabaja BS, Tzankov A, Visco C, Miranda RN, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WL, Van Krieken JH, Huh J, et al. Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program Blood. 122: 641-641. DOI: 10.1182/blood.V122.21.641.641  0.371
2013 Dabaja BS, Tsang R, Qi S, Allen P, Hodgson DC, Ricardi U, Hoppe RT, Ng A, Specht L, Li Y, Terezakis S, Constine L, Yahalom J. Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG) Blood. 122: 4292-4292. DOI: 10.1182/Blood.V122.21.4292.4292  0.496
2013 Xu-Monette ZY, Dabaja BS, Tzankov A, Visco C, Miranda RN, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WL, Krieken JHJMV, Huh J, et al. Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program Blood. 122: 213-213. DOI: 10.1182/Blood.V122.21.213.213  0.475
2013 Oki Y, Noorani M, Davis RE, Neelapu SS, Rodriguez A, Hagemeister FB, Fowler N, Wang M, Fanale MA, Samaniego F, Dabaja BS, Pinnix C, Kwak LW, Romaguera JE, Khouri I, et al. Double Hit Lymphoma: M.D. Anderson Experience Blood. 122: 1776-1776. DOI: 10.1182/Blood.V122.21.1776.1776  0.584
2013 Dabaja B, Voong K, McSpadden K, Pinnix C, Shihadeh F, Reed V, Salehpour M, Arzu I, Wang H, Garcia J. Intensity Modulated Radiation Therapy (IMRT) Using Butterfly Technique Offers a Dosimetric Advantage to Critical Organs in Young Female Patients With Mediastinal Hodgkin Lymphoma International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.422  0.642
2013 Dabaja B, Wang H, Voong K, Pinnix C, Shihadeh F, Reed V, Salehpour M, Arzu I, Garcia J. Image Guided Radiation Therapy Proves its Benefit in Detecting the Daily Unpredictable Shape Change of the Stomach: A Study of Patients Treated for Stomach Lymphoma International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.421  0.645
2013 Walker GV, Shihadeh F, Kantarjian H, Gidley PW, Arzu I, Pinnix CC, Reed VK, Dabaja BS. Controlling Central Nervous System Leukemia: Does the Extent of the Radiation Therapy Field Influence Outcomes? International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.161  0.616
2013 Pinnix CC, Perrin K, Reed VK, Shank JH, Shihadeh F, Arzu I, Horace P, Salehpour M, Garcia JA, Dabaja BS. Intensity Modulated Radiation Therapy Using Frontal Technique With Active Breathing Control in the Treatment of Gastric MALT Lymphoma: Implications for Normal Tissue Sparing International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1473  0.552
2013 Dabaja B, Voong R, Shihadeh F, Arzu I, Pinnix C, Mazloom A, Medeiros L, Romaguera J, Rodriguez M, Allen P. Radiation Therapy Is a Very Effective Modality in the Treatment of Mantle Cell Lymphoma, >80% Complete Disappearance of Disease Site in Heavily Pretreated Patients International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1470  0.672
2012 Sharp H, Grosshans D, Kadia T, Dabaja BS. Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia. Bmj Case Reports. 2012. PMID 22787181 DOI: 10.1136/Bcr.02.2012.5742  0.434
2012 Pinnix CC, Reed V, Dabaja B. Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 815-9. PMID 22773797 DOI: 10.6004/Jnccn.2012.0085  0.614
2012 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, et al. Hodgkin lymphoma, version 2.2012: Featured updates to the NCCN guidelines Jnccn Journal of the National Comprehensive Cancer Network. 10: 589-597. PMID 22570290 DOI: 10.6004/Jnccn.2012.0061  0.465
2012 Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 37: 374-82. PMID 22513213 DOI: 10.1016/J.Meddos.2012.02.003  0.393
2012 Younes A, Oki Y, McLaughlin P, Copeland AR, Goy A, Pro B, Feng L, Yuan Y, Chuang HH, Macapinlac HA, Hagemeister F, Romaguera J, Samaniego F, Fanale MA, Dabaja BS, et al. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Blood. 119: 4123-8. PMID 22371887 DOI: 10.1182/blood-2012-01-405456  0.321
2012 Batty N, Hagemeister FB, Feng L, Romaguera JE, Rodriguez MA, McLaughlin P, Samaniego F, Copeland A, Dabaja BS, Younes A. Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study. Leukemia & Lymphoma. 53: 801-6. PMID 22023528 DOI: 10.3109/10428194.2011.631160  0.408
2012 Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer. 118: 112-7. PMID 21692072 DOI: 10.1002/Cncr.26253  0.314
2012 Oki Y, Chuang H, Chasen B, Pan T, Fanale MA, Dabaja BS, Fowler NH, Romaguera JEE, Fayad LE, Hagemeister FB, Rodriguez A, Neelapu SS, Samaniego F, Kwak LW, Younes A. The Prognostic Value of Interim PET Scan in Patients with Classical Hodgkin Lymphoma Blood. 120: 1529-1529. DOI: 10.1182/Blood.V120.21.1529.1529  0.337
2012 Dabaja B, Liang F, Shihadeh F, Etzel C, Medeiros L, Fayad L, Oki Y, Hagemeister F, Rodriguez A. Mid-therapy Positron Emission Tomography Scans Significantly Predict Outcome in Patients With Diffuse Large B-cell Lymphoma (DLBCL) Treated With Chemotherapy Alone But Not When Consolidation Radiation is Added International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.294  0.396
2011 Allen P, Dabaja BS, Shihadeh FD, Nickerson P, Ballas LK. Hodgkin lymphoma: Use of modern combined modality therapy and its effect on the risk of second malignancies: The M. D. Anderson Experience over five decades. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e18529. PMID 28023296 DOI: 10.1200/Jco.2011.29.15_Suppl.E18529  0.463
2011 Dabaja BS, Phan J, Medeiros L, Chuang H, Fayad L, Hagemeister F, Shihadeh FD, Allen P, Rodriguez MA. Clinical implications of PET-negative residual disease at the completion of chemotherapy for diffuse large B-cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e18516. PMID 28023245 DOI: 10.1200/Jco.2011.29.15_Suppl.E18516  0.426
2011 Phan J, Mazloom A, Abboud M, Salehpour M, Reed V, Zreik T, Shihadeh F, Fisher C, Wogan C, Dabaja B. Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. American Journal of Clinical Oncology. 34: 499-505. PMID 21537149 DOI: 10.1097/Coc.0B013E3181F477A8  0.534
2011 Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, Arzu IY, Orlowski RZ, Thomas SK, Shihadeh F, Alexanian R, Dabaja BS. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer. 117: 4468-74. PMID 21437886 DOI: 10.1002/Cncr.26031  0.453
2011 Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, Garcia JA, Cox JD. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. International Journal of Radiation Oncology, Biology, Physics. 81: 167-74. PMID 20643518 DOI: 10.1016/J.Ijrobp.2010.05.007  0.572
2011 Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's lymphoma in young female patients: a new technique to avoid the breasts and decrease the dose to the heart. International Journal of Radiation Oncology, Biology, Physics. 79: 503-7. PMID 20418023 DOI: 10.1016/J.Ijrobp.2009.11.013  0.355
2011 Ballas LK, Fanale MA, Younes A, Milbourne A, Shirvani S, Shihadeh FD, Dabaja BS. Hodgkin lymphoma and pregnancy: Outcomes based on modern chemotherapy and radiotherapy. Journal of Clinical Oncology. 29: e18501-e18501. DOI: 10.1200/Jco.2011.29.15_Suppl.E18501  0.342
2011 Dabaja BS, Phan J, Medeiros LJ, Hagemeister FB, Chuang H, Fayad L, Shihadeh F, Allen P, Wogan C, Rodriguez MA. Clinical Implications of PET-Negative Residual Disease At the Completion of Chemotherapy for Diffuse Large B-Cell Lymphoma Blood. 118: 2695-2695. DOI: 10.1182/Blood.V118.21.2695.2695  0.489
2011 Dabaja BS, Shihadeh F, Etzel C, Fu-wen L, Shirvani SM, Ballas L, Allen P, Rodriguez MA, Fanale MA, Younes A. Continuous Decline in Second Malignancy Occurrence in Patients with Hodgkin Lymphoma; Analysis of 1670 Patients Over the Past 5 Decades Blood. 118: 2694-2694. DOI: 10.1182/Blood.V118.21.2694.2694  0.43
2011 Ballas L, I-Wen P, Guadagnolo B, Smith B, Buchholz T, Dabaja B. Trends in Utilization of Intensity Modulated Radiotherapy in Diffuse Large B-cell Lymphoma in the U.S. From 2001 to 2005: A Population-based Study International Journal of Radiation Oncology*Biology*Physics. 81: S571. DOI: 10.1016/J.Ijrobp.2011.06.1067  0.338
2010 Dabaja B, Perrin KJ, Romaguera JE, Horace P, Wogan CF, Shihadeh F, Salehpour MR. Successful treatment of a free-moving abdominal mass with radiation therapy guided by cone-beam computed tomography: a case report. Journal of Medical Case Reports. 4: 329. PMID 20958963 DOI: 10.1186/1752-1947-4-329  0.434
2010 Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, Hadziahmetovic M, Asmar N, Munkarah AR, Ayoub CM, Shihadeh F, Berjawi G, Hannoun A, Zalloua P, Wogan C, ... Dabaja B, et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Research and Treatment. 124: 13-26. PMID 20809361 DOI: 10.1007/S10549-010-1140-4  0.492
2010 Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4170-6. PMID 20713859 DOI: 10.1200/Jco.2009.27.3441  0.492
2010 Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer. 116: 3825-9. PMID 20564093 DOI: 10.1002/Cncr.25138  0.346
2010 Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, Pro B, Gonzalez G, Iyengar P, Urbauer DL, Dabaja BS. Marginal zone lymphomas: factors that affect the final outcome. Cancer. 116: 4291-8. PMID 20549822 DOI: 10.1002/Cncr.25325  0.366
2010 Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leukemia & Lymphoma. 51: 1217-24. PMID 20443676 DOI: 10.3109/10428191003793358  0.446
2010 Reed VK, Shah JJ, Mazloom A, Weber DM, Phan J, Orlowski RZ, Thomas SK, Wang M, Alexanian R, Dabaja BS. Outcome and prognostic factors in solitary plasmacytoma. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E18512  0.46
2010 Batty N, Hagemeister FB, Romaguera JE, Rodriguez MA, McLaughlin P, Samaniego F, Copeland A, Dabaja BS, Younes A. ABVD chemotherapy with interferon for advanced-stage classical Hodgkin's lymphoma: A 10-year follow-up study. Journal of Clinical Oncology. 28: 8057-8057. DOI: 10.1200/Jco.2010.28.15_Suppl.8057  0.405
2010 Fanale MA, Lai C, McLaughlin P, Romaguera J, Fayad L, Hagemeister F, Samaniego F, Rodriguez MA, Neelapu SS, Shah JJ, Kwak L, Dong W, Reed V, Dabaja BS, Popat U, et al. Outcomes of Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Patients Treated with R-CHOP. Blood. 116: 2812-2812. DOI: 10.1182/Blood.V116.21.2812.2812  0.473
2009 Phan J, Mazloom A, Abboud M, Reed VK, Dabaja BS. Supradiaphragmatic Consolidative Radiation Therapy in the Management of Stage III Hodgkin's Disease Treated with ABVD-Based Chemotherapy. Blood. 114: 4635-4635. DOI: 10.1182/Blood.V114.22.4635.4635  0.417
2009 Mazloom A, Fowler N, Iyengar P, Dabaja BS. Primary Testicular Diffuse Large B-Cell Lymphoma, M.D. Anderson Cancer Center Experience. Blood. 114: 2697-2697. DOI: 10.1182/Blood.V114.22.2697.2697  0.462
2009 Phan J, Mazloom A, Shihadeh F, Munsell M, Rodriguez A, Fayad L, Fowler N, Dabaja B. Outcome of Patients with Diffuse Large B Cell Lymphoma is Directly Related to Type of Chemotherapy and the use of Radiation International Journal of Radiation Oncology*Biology*Physics. 75: S478-S479. DOI: 10.1016/J.Ijrobp.2009.07.1092  0.466
2008 Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, et al. Hodgkin disease/lymphoma. Journal of the National Comprehensive Cancer Network : Jnccn. 6: 594-622. PMID 18597713 DOI: 10.6004/Jnccn.2008.0046  0.35
2008 Mazloom A, Reed VK, Cabanillas F, Fayad L, Pro B, Iyengar P, McLaughlin P, Urbauer DL, Dabaja BS. Marginal Zone Lymphoma: Factors That Affect the Final Outcome, a Study of 275 Patients Blood. 112: 3764-3764. DOI: 10.1182/Blood.V112.11.3764.3764  0.433
2008 Dabaja B. Young Female Patients with Hodgkin's Lymphoma can be Safely Treated with Involved Field Radiation - New Technique to Avoid the Breasts and Decrease the Heart Dose International Journal of Radiation Oncology*Biology*Physics. 72: S473. DOI: 10.1016/J.Ijrobp.2008.06.1400  0.388
2007 Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3-5. PMID 17194900 DOI: 10.1200/Jco.2006.08.8195  0.627
2007 Ha C, Kong J, Dabaja B, Fayad L, Hess M, Kim E, Podoloff D, Cabanillas F, Cox J, Macapinlac H. How Often Does 18F-FDG PET Scan Change Management During Treatment of Hodgkin Lymphoma (HL)? International Journal of Radiation Oncology*Biology*Physics. 69: S544. DOI: 10.1016/J.Ijrobp.2007.07.1792  0.458
2005 Dabaja B, Salehpour MR, Rosen I, Tung S, Morrison WH, Ang KK, Garden AS. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. International Journal of Radiation Oncology, Biology, Physics. 63: 1000-5. PMID 15978743 DOI: 10.1016/J.Ijrobp.2005.03.069  0.37
2003 Cox JD, Ha CS, Lee HK, Dabaja BS, Wilder RB. Uncertainties in contemporary treatment of aggressive lymphomas. Rays. 28: 289-92. PMID 15018315  0.597
2003 Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer Journal (Sudbury, Mass.). 9: 321-4. PMID 12967143 DOI: 10.1097/00130404-200307000-00015  0.492
2003 Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer. 98: 1021-8. PMID 12942571 DOI: 10.1002/cncr.11627  0.549
2002 Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer. 94: 2738-44. PMID 12173345 DOI: 10.1002/Cncr.10552  0.623
2001 Dabaja BS, O'brien SM, Kantarjian HM, Cortes JE, Thomas DA, Albitar M, Schlette ES, Faderl S, Sarris A, Keating MJ, Giles FJ. Fractionated Cyclophosphamide, Vincristine, Liposomal Daunorubicin (Daunoxome), and Dexamethasone (HyperCVXD) Regimen in Richter's Syndrome Leukemia & Lymphoma. 42: 329-337. PMID 11699397 DOI: 10.3109/10428190109064589  0.442
Show low-probability matches.